Related Experiment Video
Updated: Aug 17, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells
Soo-Jin Jeong1, Cynthia A Pise-Masison, Michael F Radonovich
1Virus Tumor Biology Section, Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA.
Abstract:
AKT activation enhances resistance to apoptosis and induces cell survival signaling through multiple downstream pathways. We now present evidence that AKT is activated in HTLV-1-transformed cells and that Tax activation of AKT is linked to NF-kappaB activation, p53 inhibition and cell survival. Overexpression of AKT wild type (WT), but not a kinase dead (KD) mutant, resulted in increased Tax-mediated NF-kappaB activation. Blocking AKT with the PI3K/AKT inhibitor LY294002 or AKT SiRNA prevented NF-kappaB activation and inhibition of p53. Treatment of C81 cells with LY294002 resulted in an increase in the p53-responsive gene MDM2, suggesting a role for AKT in the Tax-mediated regulation of p53 transcriptional activity. Further, we show that LY294002 treatment of C81 cells abrogates in vitro IKKbeta phosphorylation of p65 and causes a reduction of p65 Ser-536 phosphorylation in vivo, steps critical to p53 inhibition. Interestingly, blockage of AKT function did not affect IKKbeta phosphorylation of IkappaBalpha in vitro suggesting selective activity of AKT on the IKKbeta complex. Finally, AKT prosurvival function in HTLV-1-transformed cells is linked to expression of Bcl-xL. We suggest that AKT plays a role in the activation of prosurvival pathways in HTLV-1-transformed cells, possibly through NF-kappaB activation and inhibition of p53 transcription activity.
Insights
The AKT pathway promotes survival in HTLV-1-transformed cells by activating NF-kappaB and inhibiting p53. Blocking AKT function disrupts these survival signals, offering potential therapeutic targets.
Area of Science:
- Cell Biology
- Molecular Oncology
- Virology
Background:
- Human T-lymphotropic virus type 1 (HTLV-1) infection is linked to adult T-cell leukemia/lymphoma.
- AKT activation is crucial for cell survival and resistance to apoptosis.
- The Tax protein of HTLV-1 plays a significant role in viral pathogenesis.
Purpose of the Study:
- To investigate the role of AKT activation in HTLV-1-transformed cells.
- To elucidate the relationship between Tax, AKT, NF-kappaB, and p53 signaling.
- To explore AKT's contribution to cell survival in HTLV-1 infection.
Main Methods:
- Overexpression of wild-type (WT) and kinase-dead (KD) AKT mutants.
- Inhibition of AKT using LY294002 (PI3K/AKT inhibitor) and AKT siRNA.
- Assessment of NF-kappaB and p53 activity.
- Analysis of IKKbeta and p65 phosphorylation.
- Evaluation of Bcl-xL expression.
Main Results:
- AKT is activated in HTLV-1-transformed cells, with Tax mediating this activation.
- AKT activation enhances Tax-induced NF-kappaB activation and p53 inhibition.
- Blocking AKT function prevents NF-kappaB activation and restores p53 activity.
- AKT influences p53 transcriptional activity and p65 phosphorylation at Ser-536.
- AKT's prosurvival role is associated with Bcl-xL expression.
Conclusions:
- AKT signaling is a key mediator of prosurvival pathways in HTLV-1-transformed cells.
- Tax-mediated AKT activation contributes to NF-kappaB activation and p53 inhibition.
- Targeting the AKT pathway may represent a therapeutic strategy for HTLV-1-associated malignancies.
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle

